In Canada to advance early-stage technologies related to Type I and Type II diabetes.
Only by scientists functioning across Alberta will we find better treatments together. .. Alberta collaborates with Janssen to advance early-stage technologies linked to diabetes The Alberta Diabetes Institute at the University of Alberta has announced a fresh collaboration with Janssen Inc. In Canada to advance early-stage technologies related to Type I and Type II diabetes. Janssen is portion of the Janssen Pharmaceutical Businesses of Johnson & Johnson. The Johnson & Johnson Diabetes Research Fund can be a newly-created $600,000 partnership, funded between Janssen, the nationwide government of Alberta, and the Alberta Diabetes Foundation.McLoon, PhD J. Tag Petrash, PhD Robert D. Reinecke, MD Harris Ripps, PhD, DSc Mary Ann Stepp, PhD Richard A. Stone, MD Shambhu D. Varma, PhD Martin B. Wax, MD Sebastian Wolf, MD, PhD 2011 Silver Fellows Ata A. Abdel-Latif, PhD Tag B. Abelson, MD Albert J. Ahumada, Jr., PhD Christopher Baudouin, MD, PhD Anders Costs, MD Douglas Borchman, PhD Curtis R. Brandt, PhD Nicholas Brecha, PhD Mitchell G. Brigell, PhD Chandler R. Dawson, MD Paul G. FitzGerald, PhD Wilson S. Geisler, PhD Dayle H. Geroski, PhD Robert E. Hausman, PhD David G. Hunter, MD, PhD Mark E. Ireland, PhD Carolyn M. Kalsow, PhD J. Daniel Nelson, MD Maureen K. Powers, PhD John C. Saari, PhD Steven D. Schwartz, MD Marvin L. Sears, MD Arun D. Singh, MD Einar Stefansson, MD Frank Thorn, OD, PhD Joyce Tombran-Tink, PhD David R.